- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Intratumoral heterogeneity impacts the response to anti-neu antibody therapy ; volume:14 ; number:1 ; day:1 ; month:9 ; year:2014 ; pages:1-12 ; date:12.2014
BMC cancer ; 14, Heft 1 (1.9.2014), 1-12, 12.2014
- Creator
-
Song, Hyunkeun
- Contributor
-
Kim, Tae Oh
Ma, Sun Young
Park, Jin-Hee
Choi, Jae-Hyug
Kim, Jin-Ho
Kang, Mi Seon
Bae, Sang Kyun
Kim, Ki Hyaung
Kim, Tae Hyun
Seo, Su-Kil
Choi, Il Whan
Song, Geun Am
Mortenson, Eric D.
Fu, Yang-Xin
Park, SaeGwang
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-14-647
- URN
-
urn:nbn:de:1111-2016030419112
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Song, Hyunkeun
- Kim, Tae Oh
- Ma, Sun Young
- Park, Jin-Hee
- Choi, Jae-Hyug
- Kim, Jin-Ho
- Kang, Mi Seon
- Bae, Sang Kyun
- Kim, Ki Hyaung
- Kim, Tae Hyun
- Seo, Su-Kil
- Choi, Il Whan
- Song, Geun Am
- Mortenson, Eric D.
- Fu, Yang-Xin
- Park, SaeGwang
- SpringerLink (Online service)
Other Objects (12)
Estimating Intratumoral Heterogeneity from Spatiotemporal Data
Highlight report : intratumoral metabolomic heterogeneity of breast cancer
Reshaping Intratumoral Mononuclear Phagocytes with Antibody‐Opsonized Immunometabolic Nanoparticles
epihet for intra-tumoral epigenetic heterogeneity analysis and visualization
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay
Intratumoral heterogeneity of endogenous tumor cell invasive behavior in human glioblastoma
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
Osteosarcoma tumors maintain intra-tumoral transcriptional heterogeneity during bone and lung colonization
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Estimating Intratumoral Heterogeneity from Spatiotemporal Data
Highlight report : intratumoral metabolomic heterogeneity of breast cancer
Reshaping Intratumoral Mononuclear Phagocytes with Antibody‐Opsonized Immunometabolic Nanoparticles
epihet for intra-tumoral epigenetic heterogeneity analysis and visualization
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay
Intratumoral heterogeneity of endogenous tumor cell invasive behavior in human glioblastoma
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
Osteosarcoma tumors maintain intra-tumoral transcriptional heterogeneity during bone and lung colonization
Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer
Estimating Intratumoral Heterogeneity from Spatiotemporal Data
Highlight report : intratumoral metabolomic heterogeneity of breast cancer
Reshaping Intratumoral Mononuclear Phagocytes with Antibody‐Opsonized Immunometabolic Nanoparticles
epihet for intra-tumoral epigenetic heterogeneity analysis and visualization
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates
Reproducibility and intratumoral heterogeneity of the PAM50 breast cancer assay
Intratumoral heterogeneity of endogenous tumor cell invasive behavior in human glioblastoma
Intratumoral heterogeneity in a minority of ovarian low-grade serous carcinomas
P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer
Osteosarcoma tumors maintain intra-tumoral transcriptional heterogeneity during bone and lung colonization